Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales By: CNBC.com News April 25, 2024 at 06:32 AM EDT The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales By: CNBC.com News April 25, 2024 at 06:32 AM EDT The first-quarter results come as Merck shows substantial progress in preparing for Keytruda's patent expiration in 2028. Read More >>